Adriamycin pfs and Dysphemia - a phase IV clinical study of FDA data

Summary:

Dysphemia is reported as a side effect among people who take Adriamycin pfs (doxorubicin hydrochloride), especially for people who are female, 50-59 old, also take Ativan, and have Breast cancer.

The phase IV clinical study analyzes which people have Dysphemia when taking Adriamycin pfs. It is created by eHealthMe based on reports of 6,484 people who have side effects when taking Adriamycin pfs from the FDA, and is updated regularly.

What is Adriamycin pfs?

Adriamycin pfs has active ingredients of doxorubicin hydrochloride. eHealthMe is studying from 6,495 Adriamycin pfs users. Check the latest studies of Adriamycin pfs.

What is Dysphemia?

Dysphemia (stammering or stuttering) is found to be associated with 511 drugs and 553 conditions by eHealthMe. Check the latest studies of Dysphemia.

On Jul, 11, 2026

6,484 people reported to have side effects when taking Adriamycin pfs.
Among them, 15 people (0.23%) have Dysphemia.

Among these 15 people:

What is the gender of people who have Dysphemia when taking Adriamycin pfs? *

female: 73.33 %
male: 26.67 %

What is the age of people who have Dysphemia when taking Adriamycin pfs? *

What are other drugs people take besides Adriamycin pfs? *

What are other side effects people have besides Dysphemia? *

Stress And Anxiety: 15 people, 100.00%
Hypokalemia (low potassium): 14 people, 93.33%
Hyperglycemia (high blood sugar): 14 people, 93.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 14 people, 93.33%
Pneumonia: 14 people, 93.33%
Osteonecrosis Of Jaw (death of bone of jaw): 14 people, 93.33%
Dehydration (dryness resulting from the removal of water): 14 people, 93.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 14 people, 93.33%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 93.33%
Oral Candidiasis (fungal infection of mouth): 14 people, 93.33%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 6.67%
Neoplasm Malignant (cancer tumour): 1 person, 6.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 6.67%
Breast Cancer: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Adriamycin pfs and have Dysphemia?

- Check whether Dysphemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adriamycin pfs:

Adriamycin pfs (6,495 reports)

Dysphemia treatments and more:

Dysphemia (5,151 reports)

Browse all side effects of Adriamycin pfs:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dysphemia:

Dysphemia (511 drugs)

Browse all the conditions that are associated with Dysphemia:

Dysphemia (553 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on doxorubicin hydrochloride (the active ingredients of Adriamycin pfs) and Adriamycin pfs (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.